Lawmakers might address drug shortages in FDA user-fee bill

Source: BIO SmartBrief/Reuters
House lawmakers might add language to the Prescription Drug User Fee Act to require the FDA to accelerate review of applications from companies that want to change production to address a drug shortage. Lawmakers also want drugmakers to notify the FDA of potential shortages. Reuters (1/31)